Citations (242)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
Ayşe İdil Çakmak, Yonca Akova & Nilgün Yıldırım. (2023) The Complete Success in Refractory Mooren’s Ulcer Treated with Infliximab. Ocular Immunology and Inflammation 31:4, pages 682-688.
Read now
Read now
Tao Luo, Yile Wang, Hailin Tang, Fei Zhou, Ying Chen, Bing Pei & Jinke Wang. (2022) An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases. Journal of Inflammation Research 15, pages 3447-3466.
Read now
Read now
Eleftherios Pelechas, Paraskevi V Voulgari & Alexandros A. Drosos. (2021) Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert Opinion on Drug Discovery 16:3, pages 227-234.
Read now
Read now
Sungeun Ahn, Shakina Yesmin Simu, Deok-Chun Yang, Mi Jang & Byung-Hun Um. (2021) Effects of Ginsenoside Rf on dextran sodium sulfate-induced colitis in mice. Food and Agricultural Immunology 32:1, pages 360-372.
Read now
Read now
Tanya Kowalski & Heather G Mack. (2020) Ocular complications of tumour necrosis factor alpha inhibitors. Clinical and Experimental Optometry 103:2, pages 148-154.
Read now
Read now
Sanne De Smet, Jan Dierick, Sophia Steyaert, Marie Schurgers, Christophe Van Steenkiste & Sarah Loof. (2020) Alfa-1-antitrypsin deficiency: a predisposing factor leading to invasive infections?. Infectious Diseases 52:2, pages 130-134.
Read now
Read now
Vidhi V. Shah, Erica B. Lee, Shivani Reddy, Elaine J. Lin & Jashin J. Wu. (2018) Comparison of guidelines for the use of TNF inhibitors for psoriasis in the United States, Canada, Europe and the United Kingdom: a critical appraisal and comprehensive review. Journal of Dermatological Treatment 29:6, pages 586-592.
Read now
Read now
J. M. Carrascosa & E. Del-Alcazar. (2018) New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management. Expert Review of Clinical Immunology 14:4, pages 259-273.
Read now
Read now
Boudewijn J. J. Smeets, David J. Brinkman, Eelco C. J. Horsten, Jacqueline A. E. Langius, Harm J. T. Rutten, Wouter J. de Jonge & Misha D. P. Luyer. (2018) The Effect of Myopenia on the Inflammatory Response Early after Colorectal Surgery. Nutrition and Cancer 70:3, pages 460-466.
Read now
Read now
Elena Krayukhina, Masanori Noda, Kentaro Ishii, Takahiro Maruno, Hirotsugu Wakabayashi, Minoru Tada, Takuo Suzuki, Akiko Ishii-Watabe, Masahiko Kato & Susumu Uchiyama. (2017) Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments. mAbs 9:4, pages 664-679.
Read now
Read now
Nilmarie Ayala-Fontánez, David C Soler & Thomas S McCormick. (2016) Current knowledge on psoriasis and autoimmune diseases. Psoriasis: Targets and Therapy 6, pages 7-32.
Read now
Read now
Janina E. Linnik & Adrian Egli. (2016) Impact of host genetic polymorphisms on vaccine induced antibody response. Human Vaccines & Immunotherapeutics 12:4, pages 907-915.
Read now
Read now
Theresa G Leung & Jennifer E Thorne. (2013) Emerging drugs for the treatment of uveitis. Expert Opinion on Emerging Drugs 18:4, pages 513-521.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò & Francesco Puppo. (2013) Selective TNF-α inhibitor-induced injection site reactions. Expert Opinion on Drug Safety 12:2, pages 187-193.
Read now
Read now
Palanisamy Kanakaraj, Bridget A. Puffer, Xiao-Tao Yao, Spandana Kankanala, Ernest Boyd, Rutul R. Shah, Geping Wang, Dimki Patel, Rajesh Krishnamurthy, Shashi Kaithamana, Rodger G. Smith, David W. LaFleur, Carlos F. Barbas III, David M. Hilbert, Peter A. Kiener & Viktor V. Roschke. (2012) Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis. mAbs 4:5, pages 600-613.
Read now
Read now
Dorothee Nickles, Christina Falschlehner, Marie Metzig & Michael Boutros. (2012) A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling. Molecular and Cellular Biology 32:17, pages 3372-3381.
Read now
Read now
Meenakshi Bewtra & James D Lewis. (2010) Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 621-631.
Read now
Read now
JA Leman & AD Burden. (2008) Treatment of severe psoriasis with infliximab. Therapeutics and Clinical Risk Management 4:6, pages 1165-1176.
Read now
Read now
Brandie L Walker & Richard Leigh. (2008) Use of biologicals as immunotherapy in asthma and related diseases. Expert Review of Clinical Immunology 4:6, pages 743-756.
Read now
Read now
Fiona E McAlpine & Malú G Tansey. (2008) Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease. Journal of Inflammation Research 1, pages 29-39.
Read now
Read now
Maria Schäfers & Claudia Sommer. (2007) Anticytokine therapy in neuropathic pain management. Expert Review of Neurotherapeutics 7:11, pages 1613-1627.
Read now
Read now
Bart JF van den Bemt, Frank HJ van den Hoogen, Ferdinand C Breedveld,Hille van der Tempel & Rob Janknegt. (2006) InforMatrix®: treatment of rheumatoid arthritis using biologicals. Expert Opinion on Pharmacotherapy 7:13, pages 1769-1789.
Read now
Read now
Jean-Luc Teillaud. (2005) Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges. Expert Opinion on Biological Therapy 5:sup1, pages S15-S27.
Read now
Read now
Noah Scheinfeld. (2005) Adalimumab: a review of side effects. Expert Opinion on Drug Safety 4:4, pages 637-641.
Read now
Read now
Simon Skurkovich, Boris Skurkovich & Jeanne Kelly. (2005) Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases. Expert Review of Clinical Immunology 1:1, pages 11-25.
Read now
Read now
Articles from other publishers (217)
Komal Kolte, Vinay K. Singh & Shailykumari K. Patel. (2024) Synthesis, X-ray crystallographic, Hirshfeld, DFT study and interactions with TNFα receptors of chiral bisimines and diamines holding thiophene spacers. Journal of Molecular Structure 1300, pages 137165.
Crossref
Crossref
Estrid Thougaard, Pernille Vinther Nielsen, Amalie Forsberg, Victoria Phuong, Aitana Martínez Velasco, Agnieszka Wlodarczyk, Harald Wajant, Isabell Lang, Jens D. Mikkelsen, Bettina Hjelm Clausen, Roberta Brambilla & Kate Lykke Lambertsen. (2023) Systemic treatment with a selective TNFR2 agonist alters the central and peripheral immune responses and transiently improves functional outcome after experimental ischemic stroke. Journal of Neuroimmunology 385, pages 578246.
Crossref
Crossref
Peng Zhang, Yuwen Su, Siying Li, Hui Chen, Ruifang Wu & Haijing Wu. (2023) The roles of T cells in psoriasis. Frontiers in Immunology 14.
Crossref
Crossref
Rina Arad Yellin, Anett Hudák, Tamás Letoha & Bernard S. Green. (2023) Tumor necrosis factor alpha (TNFα)-binding imprinted polymers. A non-systemic therapeutic approach for inflammatory bowel diseases. European Journal of Medicinal Chemistry Reports 8, pages 100106.
Crossref
Crossref
Anna S. Pirogova, Natalya P. Teplyuk & Svetlana A. Konchina. (2023) The experience of follicular occlusion syndrome treatment with tumor necrosis factor inhibitors. Russian Journal of Skin and Venereal Diseases 26:2, pages 157-170.
Crossref
Crossref
Yingfang Zhang, Hang Xun, Quan Gao, Feifei Qi, Jia Sun & Feng Tang. (2023) Chemical Constituents of the Mushroom Dictyophora indusiata and Their Anti-Inflammatory Activities. Molecules 28:6, pages 2760.
Crossref
Crossref
Cong Dai, Yi-Nuo Wang, Wen-Ning Tian, Yu-Hong Huang & Min Jiang. (2023) Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
L. Larsen, K.D. Olsen, H.S. Christensen, K.H. Allin & T. Jess. (2023) Exposure to Anti-TNF Medications Does Not Increase the Risk of Cardiac Arrhythmia in Inflammatory Bowel Disease: A Population-Based Cohort Study. Gastro Hep Advances 2:4, pages 478-479.
Crossref
Crossref
Felicia Ceban & Jiaxi Xu. (2022) The Evolution of TNF-α Blockade for the Treatment of Rheumatoid Arthritis. Journal of Undergraduate Life Sciences 16:1.
Crossref
Crossref
Cong Dai, Yi-nuo Wang, Wen-ning Tian, Yu-Hong Huang & Min Jiang. (2022) The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis. International Immunopharmacology 112, pages 109269.
Crossref
Crossref
A. Norden, J.Y. Moon, S.S. Javadi, L. Munawar, J.‐T. Maul & J.J. Wu. (2022) Anti‐drug antibodies of IL‐23 inhibitors for psoriasis: a systematic review. Journal of the European Academy of Dermatology and Venereology 36:8, pages 1171-1177.
Crossref
Crossref
Chuan Qin, Sheng Yang, Yun-Hui Chu, Hang Zhang, Xiao-Wei Pang, Lian Chen, Luo-Qi Zhou, Man Chen, Dai-Shi Tian & Wei Wang. (2022) Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Romy Mosch & Henk-Jan Guchelaar. (2022) Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients. Frontiers in Immunology 13.
Crossref
Crossref
Samar A. Antar, Mohamad A. El-Gammal, Reem M. Hazem & Yasser M. Moustafa. (2022) Etanercept Mitigates Cadmium Chloride-induced Testicular Damage in Rats "An Insight into Autophagy, Apoptosis, Oxidative Stress and Inflammation". Environmental Science and Pollution Research 29:19, pages 28194-28207.
Crossref
Crossref
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Nikolaos-Panagiotis Andreou, Maria Gazouli & Ioannis E. Koutroubakis. (2022) Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease. International Journal of Colorectal Disease 37:3, pages 639-646.
Crossref
Crossref
Mohammad Bagherniya, Atena Mahdavi, Elahe Abbasi, Milad Iranshahy, Thozhukat Sathyapalan & Amirhossein Sahebkar. (2022) The effects of phytochemicals and herbal bio-active compounds on tumour necrosis factor-α in overweight and obese individuals: a clinical review. Inflammopharmacology 30:1, pages 91-110.
Crossref
Crossref
Thais Gagno Grillo, Luciana Rocha Almeida, Rodrigo Fedatto Beraldo, Mariana Barros Marcondes, Diego Aparecido Rios Queiróz, Daniel Luiz da Silva, Rodrigo Quera, Julio Pinheiro Baima, Rogerio Saad-Hossne & Ligia Yukie Sassaki. (2021) Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature. World Journal of Clinical Cases 9:33, pages 10382-10391.
Crossref
Crossref
Pengcheng Zhou, Jiali Chen, Jing He, Ting Zheng, Joseph Yunis, Victor Makota, Yannick O. Alexandre, Fang Gong, Xia Zhang, Wuxiang Xie, Yuhui Li, Miao Shao, Yanshan Zhu, Jane E. Sinclair, Miao Miao, Yaping Chen, Kirsty R. Short, Scott N. Mueller, Xiaolin Sun, Di Yu & Zhanguo Li. (2021) Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus. PLOS Pathogens 17:10, pages e1009858.
Crossref
Crossref
Mehmet Nayımoğlu, Banu Sarıfakıoğlu, Kübra Ustaömer, Murat Akgül & Ayşegül Isal Arslan. (2021) A rare localization of tuberculosis under infliximab treatment: Testicular involvement. Turkish Journal of Physical Medicine and Rehabilitation 67:3, pages 374-377.
Crossref
Crossref
Yanrong Zheng, Zhuchen Zhou, Feng Han & Zhong Chen. (2021) Autophagic regulation of neuroinflammation in ischemic stroke. Neurochemistry International 148, pages 105114.
Crossref
Crossref
SANJAY NIPANIKAR & CHITLANGE SS. (2021) EVALUATION OF ANALGESIC (IN VIVO) ACTIVITY OF ARIFLEX TABLET IN COMPARISON WITH DICLOFENAC AND ACECLOFENAC USING ACETIC ACID INDUCED WRITHING MODEL IN MICE. Asian Journal of Pharmaceutical and Clinical Research, pages 90-93.
Crossref
Crossref
Rawan Charbaji, Mrityunjoy Kar, Loryn E. Theune, Julián Bergueiro, Anne Eichhorst, Lucila Navarro, Patrick Graff, Friederike Stumpff, Marcelo Calderón & Sarah Hedtrich. (2021) Design and Testing of Efficient Mucus‐Penetrating Nanogels—Pitfalls of Preclinical Testing and Lessons Learned. Small 17:23, pages 2007963.
Crossref
Crossref
Sun Kim & Peter Edelstein. (2021) Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease. Cureus.
Crossref
Crossref
Stacy A. Rosenberg, Cesar Migliorati & Georgios E. Romanos. (2021) Is medication-related osteonecrosis of the jaw associated with tumor necrosis factor-α inhibition?. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 131:4, pages 422-427.
Crossref
Crossref
Sharif Yassin, Naomi Fliss Isakov, Yulia Ron, Nathaniel Aviv Cohen, Ayal Hirsch & Nitsan Maharshak. (2021) A watchful waiting approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype. International Journal of Colorectal Disease 36:4, pages 735-743.
Crossref
Crossref
Chunxiu Yang & Shu-Yuan Xiao. (2021) COVID-19 and inflammatory bowel disease: A pathophysiological assessment. Biomedicine & Pharmacotherapy 135, pages 111233.
Crossref
Crossref
Su Jin Choi, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park & Yong-Gil Kim. (2021) Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea. Therapeutic Advances in Gastroenterology 14, pages 175628482199779.
Crossref
Crossref
Manuel Sutter, Petr Hruz & Jan Hendrik Niess. (2021) High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients. Inflammatory Intestinal Diseases 6:3, pages 165-174.
Crossref
Crossref
Frederick “Fritz” T. Fraunfelder & Frederick “Rick” W. Fraunfelder. 2021. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects
145
171
.
Hisako Kurozumi-Karube, Koju Kamoi, Naoko Ando, Minami Uchida, Isao Hamaguchi & Kyoko Ohno-Matsui. (2020) In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study. Frontiers in Microbiology 11.
Crossref
Crossref
Bettina H. Clausen, Martin Wirenfeldt, Sofie S. Høgedal, Lars H. Frich, Helle H. Nielsen, Henrik D. Schrøder, Kamilla Østergaard, Bente Finsen, Bjarne W. Kristensen & Kate L. Lambertsen. (2020) Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke. Acta Neuropathologica Communications 8:1.
Crossref
Crossref
Meriem Manaï, Henriët van Middendorp, Dieuwke S. Veldhuijzen, Joy A. van der Pol, Tom W. J. Huizinga & Andrea W. M. Evers. (2020) Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocol. Trials 21:1.
Crossref
Crossref
Wen-Wei Lin, Yun-Chi Lu, Chih-Hung Chuang & Tian-Lu Cheng. (2020) Ab locks for improving the selectivity and safety of antibody drugs. Journal of Biomedical Science 27:1.
Crossref
Crossref
Komal Zia, Sajda Ashraf, Almas Jabeen, Maria Saeed, Mohammad Nur-e-Alam, Sarfaraz Ahmed, Adnan J. Al-Rehaily & Zaheer Ul-Haq. (2020) Identification of potential TNF-α inhibitors: from in silico to in vitro studies. Scientific Reports 10:1.
Crossref
Crossref
Seo-Young Kim, Ginnae Ahn, Hyun-Soo Kim, Jun-Geon Je, Kil-Nam Kim & You-Jin Jeon. (2020) Diphlorethohydroxycarmalol (DPHC) Isolated from the Brown Alga Ishige okamurae Acts on Inflammatory Myopathy as an Inhibitory Agent of TNF-α. Marine Drugs 18:11, pages 529.
Crossref
Crossref
Enrico Ragni, Laura Mangiavini, Marco Viganò, Anna Teresa Brini, Giuseppe Michele Peretti, Giuseppe Banfi & Laura Girolamo. (2020) Management of Osteoarthritis During the COVID‐19 Pandemic. Clinical Pharmacology & Therapeutics 108:4, pages 719-729.
Crossref
Crossref
Jiahui Zhang, Rong Ma, Aaron Blanchard, Jessica Petree, Hanjoong Jo & Khalid Salaita. (2020) Conditional Deoxyribozyme–Nanoparticle Conjugates for miRNA-Triggered Gene Regulation. ACS Applied Materials & Interfaces 12:34, pages 37851-37861.
Crossref
Crossref
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos & Diego Jaimes. (2020) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8:9, pages 303.
Crossref
Crossref
Jackline Joy Martín Lasola, Henry Kamdem, Michael W. McDaniel & Ryan M. Pearson. (2020) Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis. Frontiers in Immunology 11.
Crossref
Crossref
J M Fletcher, B Moran, A Petrasca & C M Smith. (2020) IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clinical and Experimental Immunology 201:2, pages 121-134.
Crossref
Crossref
Su Jin Choi, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo & Yong-Gil Kim. (2020) Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study. The Korean Journal of Internal Medicine 35:3, pages 723-731.
Crossref
Crossref
Cherie L. Stabler, Jaime A. Giraldo, Dora M. Berman, Kerim M. Gattás-Asfura, Melissa A. Willman, Alexander Rabassa, James Geary, Waldo Diaz, Norman M. Kenyon & Norma S. Kenyon. (2020) Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model. American Journal of Transplantation 20:3, pages 689-700.
Crossref
Crossref
SanjayU Nipanikar, Shailesh Deshpande, AshutoshH Bhosale & MayuraV Jadhav-Shinde. (2020) A clinical study to evaluate efficacy and safety of AHPL/AYTAB/0313 tablet in subjects suffering from osteoarthritis of knee(s). Journal of Family Medicine and Primary Care 9:1, pages 61.
Crossref
Crossref
Owen R. Griffiths, John Landon, Ruth E. Coxon, Keith Morris, Philip James & Rachel Adams. 2020. Inflammatory Disorders, Part A. Inflammatory Disorders, Part A
157
198
.
Kristian Leisegang, Ralf Henkel & Ashok Agarwal. (2019) Obesity and metabolic syndrome associated with systemic inflammation and the impact on the male reproductive system. American Journal of Reproductive Immunology 82:5.
Crossref
Crossref
Minna Yli-Karjanmaa, Kathrine Solevad Larsen, Christina Dühring Fenger, Lotte Kellemann Kristensen, Nellie Anne Martin, Peter Toft Jensen, Alexandre Breton, Lubov Nathanson, Pernille Vinther Nielsen, Minna Christiansen Lund, Stephanie Lindeman Carlsen, Jan Bert Gramsbergen, Bente Finsen, Jane Stubbe, Lars Henrik Frich, Helen Stolp, Roberta Brambilla, Daniel Clive Anthony, Morten Meyer & Kate Lykke Lambertsen. (2019) TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex. Brain, Behavior, and Immunity 82, pages 279-297.
Crossref
Crossref
Gaspar Diaz‐Muñoz, Izabel Luzia Miranda, Suélen Karine Sartori, Daniele Cristina Rezende & Marisa Alves Nogueira Diaz. (2019) Use of chiral auxiliaries in the asymmetric synthesis of biologically active compounds: A review. Chirality 31:10, pages 776-812.
Crossref
Crossref
Narmada Katakam, Luciano Nardo & Gavin Sacks. 2019. Subfertility, Reproductive Endocrinology and Assisted Reproduction. Subfertility, Reproductive Endocrinology and Assisted Reproduction
214
221
.
Enrico Sangiovanni, Chiara Di Lorenzo, Stefano Piazza, Yuri Manzoni, Cecilia Brunelli, Marco Fumagalli, Andrea Magnavacca, Giulia Martinelli, Francesca Colombo, Antonella Casiraghi, Gloria Melzi, Laura Marabini, Patrizia Restani & Mario Dell’Agli. (2019) Vitis vinifera L. Leaf Extract Inhibits In Vitro Mediators of Inflammation and Oxidative Stress Involved in Inflammatory-Based Skin Diseases. Antioxidants 8:5, pages 134.
Crossref
Crossref
Kate Lykke Lambertsen, Bente Finsen & Bettina Hjelm Clausen. (2018) Post-stroke inflammation—target or tool for therapy?. Acta Neuropathologica 137:5, pages 693-714.
Crossref
Crossref
Arsalan S. Haqqani & Danica B. Stanimirovic. 2019. Immunoproteomics. Immunoproteomics
309
325
.
Weifeng Xu, Michael Sank, Jennifer Cummings, Stephen Carl, Marina Juhel, Carol Gleason, Robert Dodge, Binodh S. DeSilva, Gerry Kolaitis & Renuka Pillutla. (2018) Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing. Journal of Immunological Methods 462, pages 34-41.
Crossref
Crossref
Ki Hong, Darong Kim, Bo-Kyung Kim, Seo Woo, Ji Lee, Seung-Hee Han, Gyu-Un Bae & Soosung Kang. (2018) CF3-Substituted Mollugin 2-(4-Morpholinyl)-ethyl ester as a Potential Anti-inflammatory Agent with Improved Aqueous Solubility and Metabolic Stability. Molecules 23:8, pages 2030.
Crossref
Crossref
Robi N. Maamari & Steven M. Couch. (2018) Nonspecific Orbital Inflammation. Advances in Ophthalmology and Optometry 3:1, pages 315-335.
Crossref
Crossref
Roberto Martín-de León, Jorge Moisés, Pilar Peris, Carlos Agustí & Ramón María Marrades. (2018) Nódulos pulmonares cavitados en paciente tratada con anti-TNF. Archivos de Bronconeumología 54:8, pages 431-432.
Crossref
Crossref
Roberto Martín-de León, Jorge Moisés, Pilar Peris, Carlos Agustí & Ramón María Marrades. (2018) Cavitating Pulmonary Nodules in a Patient Receiving Anti-TNF. Archivos de Bronconeumología (English Edition) 54:8, pages 431-432.
Crossref
Crossref
Laura Soong, Bahman Sotoodian & Alain Brassard. (2018) Immediate-type infliximab infusion reaction presenting as purpura. JAAD Case Reports 4:6, pages 596-598.
Crossref
Crossref
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou & Ioannis E Koutroubakis. (2018) Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 24:6, pages 1266-1271.
Crossref
Crossref
Shani Zeeli, Tehilla Weill, Efrat Finkin-Groner, Corina Bejar, Michal Melamed, Svetlana Furman, Michael Zhenin, Abraham Nudelman & Marta Weinstock. (2018) Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory Agents. Journal of Medicinal Chemistry 61:9, pages 4004-4019.
Crossref
Crossref
Tsogzolmaa Ganbold & Huricha Baigude. (2018) Design of Mannose-Functionalized Curdlan Nanoparticles for Macrophage-Targeted siRNA Delivery. ACS Applied Materials & Interfaces 10:17, pages 14463-14474.
Crossref
Crossref
M.M.S. Nico, C.F.B. Gavioli, M.L.D. Dabronzo, R. Romiti, M.D. Takahashi & S.V. Lourenço. (2018) The many faces of tuberculosis of the oral mucosa - three cases with distinct pathomechanisms. Journal of the European Academy of Dermatology and Venereology 32:5, pages e185-e186.
Crossref
Crossref
Xiaobing Deng, Xiaoling Zhang, Bo Tang, Hongbo Liu, Qi Shen, Ying Liu & Luhua Lai. (2018) Design, Synthesis, and Evaluation of Dihydrobenzo[cd]indole-6-sulfonamide as TNF-α Inhibitors. Frontiers in Chemistry 6.
Crossref
Crossref
Shivaji S. Pandit, Mahesh R. Kulkarni, Yashwant B. Pandit, Nitin P. Lad & Vijay M. Khedkar. (2018) Synthesis and in vitro evaluations of 6-(hetero)-aryl-imidazo[1,2-b]pyridazine-3-sulfonamide’s as an inhibitor of TNF-α production. Bioorganic & Medicinal Chemistry Letters 28:1, pages 24-30.
Crossref
Crossref
Alanna M. Windsor & Michael J. Ruckenstein. 2018. Inflammatory Mechanisms in Mediating Hearing Loss. Inflammatory Mechanisms in Mediating Hearing Loss
189
210
.
K. A. Papp & Mathew N. Nicholas. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology
111
121
.
Umar Muzaffer, V. I. Paul & N. Rajendra Prasad. (2017) Molecular docking of selected phytoconstituents with signaling molecules of Ultraviolet-B induced oxidative damage. In Silico Pharmacology 5:1.
Crossref
Crossref
Khaled Greish, Safa Taha, Anfal Jasim, Sara Abd Elghany, Ameera Sultan, Ali AlKhateeb, Manal Othman, Fang Jun, Sebastien Taurin & Moiz Bakhiet. (2017) Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease. Clinical and Translational Medicine 6:1.
Crossref
Crossref
Nisha Kant Ojha, Grigory V. Zyryanov, Adinath Majee, Valery N. Charushin, Oleg N. Chupakhin & Sougata Santra. (2017) Copper nanoparticles as inexpensive and efficient catalyst: A valuable contribution in organic synthesis. Coordination Chemistry Reviews 353, pages 1-57.
Crossref
Crossref
Cuneyt Tetikkurt. (2017) Miliary Tuberculosis Occuring During Certolizumab Treatment. MOJ Clinical & Medical Case Reports 7:5.
Crossref
Crossref
Xinyao Liu, Shurong Wang, Xuanzhong Wang, Jiaming Liang & Yan Zhang. (2017) Recent drug therapies for corneal neovascularization. Chemical Biology & Drug Design 90:5, pages 653-664.
Crossref
Crossref
A. G. Kharitonov. (2017) EFFICACY AND SAFETY OF VEDOLIZUMAB IN CROHN'S DISEASE (review). Koloproktologia:3, pages 71-79.
Crossref
Crossref
Wellington K. Hsu, Christina L Goldstein, Mohammed F. Shamji, Sam K. Cho, Paul M. Arnold, Michael G. Fehlings & Tom E. Mroz. (2017) Novel Osteobiologics and Biomaterials in the Treatment of Spinal Disorders. Neurosurgery 80:3S, pages S100-S107.
Crossref
Crossref
Irfan Khan, Ashvini K. Reddy & Jennifer E. Thorne. (2017) Systemic Treatment for Noninfectious Intraocular Inflammation. Current Ophthalmology Reports 5:1, pages 98-105.
Crossref
Crossref
Shruti Agrawal, Paul Statkevich, Gaurav Bajaj, Yan Feng, Sally Saeger, Dharmesh D. Desai, Jong-Soon Park, Ian M. Waxman, Amit Roy & Manish Gupta. (2017) Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in Patients With Metastatic Solid Tumors. The Journal of Clinical Pharmacology 57:3, pages 394-400.
Crossref
Crossref
Nicolò Scuderi, Ambra Monfrecola, Luca Andrea Dessy, Gabriella Fabbrocini, Matteo Megna & Giuseppe Monfrecola. (2017) Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review. Skin Appendage Disorders 3:2, pages 95-110.
Crossref
Crossref
J.K. Durand & A.S. Baldwin. 2017. Chromatin Proteins and Transcription Factors as Therapeutic Targets. Chromatin Proteins and Transcription Factors as Therapeutic Targets
77
115
.
M.L. Smythe. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
157
170
.
Priyankar Dey & Tapas Kumar Chaudhuri. (2015) Immunomodulatory activity of Nerium indicum through inhibition of nitric oxide and cyclooxygenase activity and modulation of TH1/TH2 cytokine balance in murine splenic lymphocytes. Cytotechnology 68:4, pages 749-761.
Crossref
Crossref
Qiang Wang, Zhenzhen Wen & Qian Cao. (2016) Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: A meta-analysis. Experimental and Therapeutic Medicine.
Crossref
Crossref
Daniel R van Langenberg. (2016)
New choices, new challenges: Anti-TNF
versus
anti-integrin molecule therapy in IBD
. Journal of Gastroenterology and Hepatology 31, pages 10-11.
Crossref
Crossref
Wei Guo, Dongmei Yu, Xin Wang, Cheng Luo, Yucong Chen, Wen Lei, Chen Wang, Yaoyao Ge, Wenyao Xue, Qiqi Tian, Xiangdong Gao & Wenbing Yao. (2016) Anti-inflammatory effects of interleukin-23 receptor cytokine-binding homology region rebalance T cell distribution in rodent collagen-induced arthritis. Oncotarget 7:22, pages 31800-31813.
Crossref
Crossref
Hongjun Zhao, Chunmei Wu, Mengyun Wu, Yaou Zhou, Honglin Zhu, Yisha Li, Yunhui You, Hui Luo, Lijing Wang & Xiaoxia Zuo. (2016) Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence. Molecular Medicine Reports.
Crossref
Crossref
Gregory W. Thomas, Leonard T. Rael, Melissa Hausburg, Elizabeth D. Frederick, Charles W. Mains, Denetta Slone, Matthew M. Carrick & David Bar-Or. (2016) The low molecular weight fraction of human serum albumin upregulates production of 15d-PGJ2 in Peripheral Blood Mononuclear Cells. Biochemical and Biophysical Research Communications 473:4, pages 1328-1333.
Crossref
Crossref
Vipul Yadav, Felipe Varum, Roberto Bravo, Esther Furrer & Abdul W. Basit. (2016) Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies. International Journal of Pharmaceutics 502:1-2, pages 181-187.
Crossref
Crossref
P. Schopohl, P. Grüneberg & M.F. Melzig. (2016) The influence of harpagoside and harpagide on TNFα-secretion and cell adhesion molecule mRNA-expression in IFNγ/LPS-stimulated THP-1 cells. Fitoterapia 110, pages 157-165.
Crossref
Crossref
Qi Shen, Changsheng Zhang, Hongbo Liu, Yuting Liu, Junyue Cao, Xiaolin Zhang, Yuan Liang, Meiping Zhao & Luhua Lai. (2016) De novo design of helical peptides to inhibit tumor necrosis factor-α by disrupting its trimer formation. MedChemComm 7:4, pages 725-729.
Crossref
Crossref
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero & Nohora Rodríguez. (2016) Risk management for prescribing biological therapies. Revista Colombiana de Reumatología (English Edition) 23:1, pages 50-67.
Crossref
Crossref
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero & Nohora Rodríguez. (2016) Gestión de riesgo para la prescripción de terapias biológicas. Revista Colombiana de Reumatología 23:1, pages 50-67.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
73
97
.
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
158
170
.
Virendra N. Sehgal, Deepika Pandhi & Ananta Khurana. (2015) Biologics in dermatology: adverse effects. International Journal of Dermatology 54:12, pages 1442-1460.
Crossref
Crossref
Po-Hua Chen & Tsen-Fang Tsai. (2015) Adalimumab-induced lupus pernio-like eruption in a patient with psoriasis. Dermatologica Sinica 33:4, pages 249-250.
Crossref
Crossref
Anna Beattie, Leo F.A. Stassen & Kumara Ekanayake. (2015) Oral Squamous Cell Carcinoma Presenting in a Patient Receiving Adalimumab for Rheumatoid Arthritis. Journal of Oral and Maxillofacial Surgery 73:11, pages 2136-2141.
Crossref
Crossref
S. Prasad Gabbita, Ming F. Johnson, Naomi Kobritz, Pirooz Eslami, Aleksandra Poteshkina, Sridhar Varadarajan, John Turman, Frank Zemlan & Marni E. Harris-White. (2015) Oral TNFα Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model. PLOS ONE 10:10, pages e0137305.
Crossref
Crossref
Alan Menter, Diamant Thaçi, Kim A. Papp, Jashin J. Wu, Mareike Bereswill, Henrique D. Teixeira, Simone Rubant & David A. Williams. (2015) Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis. Journal of the American Academy of Dermatology 73:3, pages 410-419.e6.
Crossref
Crossref
Pier Luigi Meroni, Gabriele Valentini, Fabio Ayala, Antonino Cattaneo & Guido Valesini. (2015) New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis. Autoimmunity Reviews 14:9, pages 812-829.
Crossref
Crossref
Emrullah Korkmaz, Emily E. Friedrich, Mohamed H. Ramadan, Geza Erdos, Alicia R. Mathers, O. Burak Ozdoganlar, Newell R. Washburn & Louis D. FaloJr.Jr.. (2015) Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays. Acta Biomaterialia 24, pages 96-105.
Crossref
Crossref
Changda Liu, Nan Yang, Ying Song, Lixin Wang, Jiachen Zi, Shuwei Zhang, David Dunkin, Paula Busse, David Weir, Jody Tversky, Rachel L. Miller, Joseph Goldfarb, Jixun Zhan & Xiu-Min Li. (2015) Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. International Immunopharmacology 27:2, pages 224-231.
Crossref
Crossref
A. Moffett & N. Shreeve. (2015) First do no harm: uterine natural killer (NK) cells in assisted reproduction. Human Reproduction 30:7, pages 1519-1525.
Crossref
Crossref
Boonyarut Ladda, Talent Theparee, Juntana Chimchang, Somboon Tanasupawat & Malai Taweechotipatr. (2015) In vitro modulation of tumor necrosis factor α production in THP-1 cells by lactic acid bacteria isolated from healthy human infants. Anaerobe 33, pages 109-116.
Crossref
Crossref
Brian A. Baldo. (2015) Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety. Drug Safety 38:5, pages 455-479.
Crossref
Crossref
C.C. Zouboulis, N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, J. Lapins, L. Matusiak, E.P. Prens, J. Revuz, S. Schneider-Burrus, J.C. Szepietowski, H.H. van der Zee & G.B.E. Jemec. (2015) European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology 29:4, pages 619-644.
Crossref
Crossref
Ignacio García-De LaTorre & Ignacio García-Valladares. (2015) Antinuclear Antibody (ANA) Testing in Patients Treated With Biological DMARDs: Is It Useful?. Current Rheumatology Reports 17:4.
Crossref
Crossref
Teruhito Yoshitaka, Mizuho Kittaka, Shu Ishida, Noriyoshi Mizuno, Tomoyuki Mukai & Yasuyoshi Ueki. (2015) Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice. Bone 71, pages 201-209.
Crossref
Crossref
Tian ZI & Dong YU. (2015) A network pharmacology study of Sendeng-4, a Mongolian medicine. Chinese Journal of Natural Medicines 13:2, pages 108-118.
Crossref
Crossref
Utpal S. Bhalala, Raymond C. Koehler & Sujatha Kannan. (2015) Neuroinflammation and Neuroimmune Dysregulation after Acute Hypoxic-Ischemic Injury of Developing Brain. Frontiers in Pediatrics 2.
Crossref
Crossref
Simon Skurkovich, Galina Lukina, Yakov Sigidin, Olga Pushkova, Evelyna Mach & Boris Skurkovich. (2015) Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis. Journal of Immune Based Therapies, Vaccines and Antimicrobials 04:01, pages 1-8.
Crossref
Crossref
Emily E. Friedrich, Andrea Azofiefa, Evan Fisch & Newell R. Washburn. (2015) Local Delivery of Antitumor Necrosis Factor-α Through Conjugation to Hyaluronic Acid. Journal of Burn Care & Research 36:2, pages e90-e101.
Crossref
Crossref
Ka Wai Kam, Lai Shan Tam, Mang Kwan Patrick Tam & Alvin L. Young. (2015) Infliximab in the Treatment of Refractory Ocular Inflammatory Diseases. Asia-Pacific Journal of Ophthalmology 4:1, pages 19-24.
Crossref
Crossref
E. Záňová, D. Kozáková & J. Rovenský. 2015. Infection and Autoimmunity. Infection and Autoimmunity
599
618
.
. 2015. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects
47
343
.
Bettina Hjelm Clausen, Matilda Degn, Nellie Anne Martin, Yvonne Couch, Leena Karimi, Maria Ormhøj, Maria-Louise Bergholdt Mortensen, Hanne Birgit Gredal, Chris Gardiner, Ian IL Sargent, David E Szymkowski, Géraldine H Petit, Tomas Deierborg, Bente Finsen, Daniel Clive Anthony & Kate Lykke Lambertsen. (2014) Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia. Journal of Neuroinflammation 11:1.
Crossref
Crossref
Takami Sato. (2014) Tumor Necrosis Factor-α Blockade and Development of Uveal Melanoma: Expected Adverse Effect or Just Coincidence?. Mayo Clinic Proceedings 89:11, pages 1467-1470.
Crossref
Crossref
Qi Shen, Jing Chen, Qian Wang, Xiaobing Deng, Ying Liu & Luhua Lai. (2014) Discovery of highly potent TNFα inhibitors using virtual screen. European Journal of Medicinal Chemistry 85, pages 119-126.
Crossref
Crossref
Narender Annapureddy, Shiv Kumar Agarwal, Natraj Ammakkanavar, Vijay Kanakadandi, Manpreet S. Sabharwal, Hari Priya Sanjani, Priya Simoes & Girish N. Nadkarni. (2014) Tumor Necrosis Factor Inhibitor–Induced Serositis. American Journal of Therapeutics 21:5, pages e166-e168.
Crossref
Crossref
Ronald N. Kostoff. (2014) Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease. Scientometrics 100:3, pages 623-657.
Crossref
Crossref
G. Shankar, S. Arkin, L. Cocea, V. Devanarayan, S. Kirshner, A. Kromminga, V. Quarmby, S. Richards, C. K. Schneider, M. Subramanyam, S. Swanson, D. Verthelyi & S. Yim. (2014) Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations. The AAPS Journal 16:4, pages 658-673.
Crossref
Crossref
Matthew P. DeBerge, Kenneth H. Ely & Richard I. Enelow. (2014) Soluble, but Not Transmembrane, TNF-α Is Required during Influenza Infection To Limit the Magnitude of Immune Responses and the Extent of Immunopathology. The Journal of Immunology 192:12, pages 5839-5851.
Crossref
Crossref
Farnaz Fatemi, Esmaeil Sadroddiny, Azam Gheibi, Taiebeh Mohammadi Farsani & Gholam Ali Kardar. (2014) Biomolecular markers in assessment and treatment of asthma. Respirology 19:4, pages 514-523.
Crossref
Crossref
Emily E. Friedrich, Liang Tso Sun, Shanmugasundaram Natesan, David O. Zamora, Robert J. Christy & Newell R. Washburn. (2014) Effects of hyaluronic acid conjugation on anti-TNF-α inhibition of inflammation in burns. Journal of Biomedical Materials Research Part A 102:5, pages 1527-1536.
Crossref
Crossref
Ashley L. Semble, Scott A. Davis & Steven R. Feldman. (2013) Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review. American Journal of Clinical Dermatology 15:1, pages 37-43.
Crossref
Crossref
Seong Hun MoonJoo Yeon Ko. (2014) Dermatological Side Effects of Anti-tumor Necrosis Factor Alpha Therapy. Journal of Rheumatic Diseases 21:1, pages 9.
Crossref
Crossref
Mehmet Unlu, Pınar Cimen, Aysu Ayranci, Tulay Akarca, Onur Karaman & Mustafa Sevket Dereli. (2014) Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab. Respiratory Medicine Case Reports 13, pages 43-47.
Crossref
Crossref
Juan Escalas, Nicole Knöpfel, Ana Martin-Santiago & Carmen Calles. (2014) Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis. Journal of the American Academy of Dermatology 70:1, pages e17-e18.
Crossref
Crossref
Caroline Kerner. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
321
326
.
G. Rajeshwar Reddy, T. Ram Reddy, R. Gangadhara Chary, Suju C. Joseph, Soumita Mukherjee & Manojit Pal. (2013) β-Cyclodextrin mediated MCR in water: synthesis of dihydroisoindolo[2,1-a]quinazoline-5,11-dione derivatives under microwave irradiation. Tetrahedron Letters 54:49, pages 6744-6746.
Crossref
Crossref
Iman Hemmati & Jason Kur. (2013) Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature. Clinical Rheumatology 32:7, pages 1095-1098.
Crossref
Crossref
Yves J. Ribeill. 2013. The Textbook of Pharmaceutical Medicine. The Textbook of Pharmaceutical Medicine
1
31
.
Muzamal Iqbal, Robert Verpoorte, Henrie A. A. J. Korthout & Natali Rianika Mustafa. (2012) Phytochemicals as a potential source for TNF-α inhibitors. Phytochemistry Reviews 12:1, pages 65-93.
Crossref
Crossref
Takumi Matsumoto, Ichiro Nakamura, Ayumi Miura, Gen Momoyama & Katsumi Ito. (2012) New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review. Clinical Rheumatology 32:2, pages 271-275.
Crossref
Crossref
Angela Jiang, Jillian Wang, Malav Joshi & John Byron Christoforidis. (2013) Systemic Treatments for Noninfectious Vitreous Inflammation. Mediators of Inflammation 2013, pages 1-11.
Crossref
Crossref
Sougata Santra, Avik Kumar Bagdi, Adinath Majee & Alakananda Hajra. (2013) Metal nanoparticles in “on-water” organic synthesis: one-pot nano CuO catalyzed synthesis of isoindolo[2,1-a]quinazolines. RSC Advances 3:47, pages 24931.
Crossref
Crossref
Abd Al Rahman Al-Shudiefat, Anita K. Sharma, Ashim K. Bagchi, Sanjiv Dhingra & Pawan K. Singal. (2012) Oleic acid mitigates TNF-α-induced oxidative stress in rat cardiomyocytes. Molecular and Cellular Biochemistry 372:1-2, pages 75-82.
Crossref
Crossref
Arsalan S. Haqqani & Danica B. Stanimirovic. 2013. Immunoproteomics. Immunoproteomics
345
360
.
Olayemi Sokumbi, David A. Wetter, Ashima Makol & Kenneth J. Warrington. (2012) Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors. Mayo Clinic Proceedings 87:8, pages 739-745.
Crossref
Crossref
Nataraju Angaswamy, Naohiko Fukami, Venkataswarup Tiriveedhi, George J. Cianciolo & T. Mohanakumar. (2012) LMP-420, a Small Molecular Inhibitor of TNF-α, Prolongs Islet Allograft Survival by Induction of Suppressor of Cytokine Signaling-1: Synergistic Effect with Cyclosporin-A. Cell Transplantation 21:6, pages 1285-1296.
Crossref
Crossref
Neha Chauhan, Rajeev Taliyan & Pyare Lal Sharma. (2012) Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain. Naunyn-Schmiedeberg's Archives of Pharmacology 385:5, pages 527-538.
Crossref
Crossref
Alexander Nast, Wolf-Henning Boehncke, Ulrich Mrowietz, Hans-Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Adel Sammain, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Matthias Augustin, Ricardo Erdmann, Joachim Klaus, Joachim Koza, Siegrid Muller, Hans-Dieter Orzechowski, Stefanie Rosumeck, Gerhard Schmid-Ott, Tobias Weberschock & Berthold Rzany. (2012) S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 10, pages S1-s95.
Crossref
Crossref
Eduardo Puertas-Abreu, Elaudi Polanco, Miriam Azocar, Luis Mundarain, Concepción Nuñez-Sotelo, Rafael Montaño, Freddy Vivas, Zair Noguera, Francisco Marín, Omar Bellorin, José Rivas, Eduardo Toro, Eugenia Benzaquen, Mayra Rauseo & Luis Gutiérrez González. (2012) Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α. International Archives of Medicine 5:1, pages 7.
Crossref
Crossref
John B. Christoforidis, Susie Chang, Angela Jiang, Jillian Wang & Colleen M. Cebulla. (2012) Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation 2012, pages 1-10.
Crossref
Crossref
Dulgeroglu Deniz, Umay Ebru, Bal Ajda, Tetik Menevse Gulsum, Tatlican Semih & Cakci Aytul. (2009) A case of cellulitis causing tissue defect during etanercept therapy. Rheumatology International 32:1, pages 241-244.
Crossref
Crossref
Chelsea Cavanagh, Jessica Colby-Milley, Mark Farso, Slavica Krantic & Remi Quirion. (2011) Early molecular and synaptic dysfunctions in the prodromal stages of Alzheimer’s disease: focus on TNF-α and IL-1β. Future Neurology 6:6, pages 757-769.
Crossref
Crossref
Huaiping Yuan, Rohit Gupte, Sami Zelkha & Salomon Amar. (2011) Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. Journal of Clinical Periodontology 38:11, pages 1029-1036.
Crossref
Crossref
Khayyam Durrani, Fouad R. Zakka, Muna Ahmed, Mohiuddin Memon, Sana S. Siddique & C. Stephen Foster. (2011) Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease. Survey of Ophthalmology 56:6, pages 474-510.
Crossref
Crossref
NADA ALAAEDDINE, GEORGE HILAL, RAFFIC BADDOURA, JOHN ANTONIOU & JOHN A. Di BATTISTA. (2011) CCL20 Stimulates Proinflammatory Mediator Synthesis in Human Fibroblast-like Synoviocytes Through a MAP Kinase-dependent Process with Transcriptional and Posttranscriptional Control. The Journal of Rheumatology 38:9, pages 1858-1865.
Crossref
Crossref
Y. Imamura, H. Wang, N. Matsumoto, T. Muroya, J. Shimazaki, H. Ogura & T. Shimazu. (2011) Interleukin-1β causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience 187, pages 63-69.
Crossref
Crossref
Christine Grigorakaki, Franck Morceau, Sébastien Chateauvieux, Mario Dicato & Marc Diederich. (2011) Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression. Biochemical Pharmacology 82:2, pages 156-166.
Crossref
Crossref
Ronni Wolf, Jasna Lipozenčić & Batya B. Davidovici. 2011. Emergency Dermatology. Emergency Dermatology
168
177
.
K. Siva Kumar, P. Mahesh Kumar, K. Anil Kumar, M. Sreenivasulu, Ahamed A. Jafar, D. Rambabu, G. Rama Krishna, C. Malla Reddy, Ravikumar Kapavarapu, K. Shivakumar, K. Krishna Priya, Kishore V. L. Parsa & Manojit Pal. (2011) A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α. Chemical Communications 47:17, pages 5010.
Crossref
Crossref
Camille Francès & Nicolas Kluger. 2011. Autoimmune Diseases of the Skin. Autoimmune Diseases of the Skin
405
433
.
Maria Letizia Musumeci, Francesco Lacarrubba & Giuseppe Micali. (2010) Onset of Lichen Planus During Treatment with Etanercept. American Journal of Clinical Dermatology 11, pages 55-56.
Crossref
Crossref
Leonid Timashev & Neil F. Fernandes. (2018) A Guide to the Use of Adalimumab. Psoriasis Forum 16a:2, pages 57-61.
Crossref
Crossref
Kathrin Scherer, David Spoerl & Andreas J. Bircher. (2010) Adverse drug reactions to biologics. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 8:6, pages 411-426.
Crossref
Crossref
N. Rahman, C. Healy, Stephen R. Flint & L. F. A. Stassen. (2010) Cautionary Note: A Possible Association Between Oral Squamous Cell Carcinoma and Tumor Necrosis Factor Antagonists; Need for Oral Screening. JCR: Journal of Clinical Rheumatology 16:4, pages 197-199.
Crossref
Crossref
Marina Vardanyan, Edward C. Parkin & Horacio L. Rodriguez Rilo. 2010. Immunotherapy in Transplantation. Immunotherapy in Transplantation
385
398
.
Elizabeth A. Mauldin, Daniel O. Morris, Dorothy C. Brown & Margret L. Casal. (2010) Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment. Veterinary Dermatology.
Crossref
Crossref
Danielle Levine & Bruce E. Strober. (2010) The Treatment of Moderate-to-Severe Psoriasis: Prescreening and Monitoring Psoriatic Patients on Biologics. Seminars in Cutaneous Medicine and Surgery 29:1, pages 28-34.
Crossref
Crossref
Veera S. KATIKIREDDI, Samuel L. WHITTLE & Catherine L. HILL. (2010) Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis. International Journal of Rheumatic Diseases 13:1, pages 12-26.
Crossref
Crossref
Meenakshi Bewtra & James D. Lewis. (2010) Safety Profile of IBD: Lymphoma Risks. Medical Clinics of North America 94:1, pages 93-113.
Crossref
Crossref
Carlos Ferrándiz, Jose Manuel Carrascosa & Aram Boada. (2010) A new era in the management of psoriasis? The biologics: facts and controversies. Clinics in Dermatology 28:1, pages 81-87.
Crossref
Crossref
. 2010. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs
371
667
.
Meenakshi Bewtra & James D. Lewis. (2009) Safety Profile of IBD: Lymphoma Risks. Gastroenterology Clinics of North America 38:4, pages 669-689.
Crossref
Crossref
David A. Wetter & Mark D.P. Davis. (2009) Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic. Mayo Clinic Proceedings 84:11, pages 979-984.
Crossref
Crossref
Maximilian Y. Emmert, Sacha P. Salzberg, Lorenz S. Emmert, Sohil Behjati, Andre Plass, Christian Felix, Volkmar Falk & Juerg Gruenenfelder. (2009) Severe cardiomyopathy following treatment with the tumour necrosis factor‐α inhibitor adalimumab for Crohn's disease. European Journal of Heart Failure 11:11, pages 1106-1109.
Crossref
Crossref
A. Rousseau, R. Taberne, F. Siberchicot, J.-C. Fricain & N. Zwetyenga. (2009) Carcinome jugal sous étanercept. Revue de Stomatologie et de Chirurgie Maxillo-faciale 110:5, pages 306-308.
Crossref
Crossref
Mohammed F. Shamji, Priscilla Hwang, Robert W. Bullock, Samuel B. Adams, Dana L. Nettles & Lori A. Setton. (2008) Release and activity of anti-TNFα therapeutics from injectable chitosan preparations for local drug delivery. Journal of Biomedical Materials Research Part B: Applied Biomaterials 90B:1, pages 319-326.
Crossref
Crossref
Rita V. Patel, Lily N. Clark, Mark Lebwohl & Jeffrey M. Weinberg. (2009) Treatments for psoriasis and the risk of malignancy. Journal of the American Academy of Dermatology 60:6, pages 1001-1017.
Crossref
Crossref
Ditina Desai, Raphaela Goldbach-Mansky, Joshua D Milner, Ronald L Rabin, Keith Hull, Frank Pucino & Nona Colburn. (2009) Anaphylactic Reaction to Anakinra in a Rheumatoid Arthritis Patient Intolerant to Multiple Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs. Annals of Pharmacotherapy 43:5, pages 967-972.
Crossref
Crossref
Fiona E. McAlpine, Jae-Kyung Lee, Ashley S. Harms, Kelly A. Ruhn, Mathew Blurton-Jones, John Hong, Pritam Das, Todd E. Golde, Frank M. LaFerla, Salvatore Oddo, Armin Blesch & Malú G. Tansey. (2009) Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiology of Disease 34:1, pages 163-177.
Crossref
Crossref
M Yadira Hurley, Mary Noel George, Craig L Leonardi & John L Frater. (2008) A transient benign lymph node-based proliferation of T-cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and CD11a antagonists. Diagnostic Pathology 3:1.
Crossref
Crossref
AC Davaine, A Saraux, S Prigent, I Kupfer-Bessaguet, D Roswag, P Plantin, P Schoenlaub, F Talarmin, A Zagnoli & L Misery. (2008) Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study. Journal of the European Academy of Dermatology and Venereology 22:12, pages 1471-1477.
Crossref
Crossref
Martina Kucharekova, Véronique Winnepenninckx, Jorge Frank & Pamela Poblete-Gutiérrez. (2008) Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - a therapeutic challenge. International Journal of Dermatology 47, pages 25-28.
Crossref
Crossref
John C. DavisJrJr & Philip J. Mease. (2008) Insights Into the Pathology and Treatment of Spondyloarthritis: From the Bench to the Clinic. Seminars in Arthritis and Rheumatism 38:2, pages 83-100.
Crossref
Crossref
C. Pföhler & S. Ugurel. (2008) Kutane Nebenwirkungen molekular zielgerichteter TherapienCutaneous reactions to molecular targeted therapies. Der Hautarzt 59:10, pages 814-820.
Crossref
Crossref
Melissa K McCoy, Kelly A Ruhn, Terina N Martinez, Fiona E McAlpine, Armin Blesch & Malú G Tansey. (2008) Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian rats. Molecular Therapy 16:9, pages 1572-1579.
Crossref
Crossref
Displaying 200 of 242 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list